Expression of Tgfβ1 and inflammatory markers in the 6-hydroxydopamine mouse model of Parkinson´s disease
Parkinson´s disease (PD) is a neurodegenerative disorder that is characterised by loss of midbrain dopaminergic (mDA) neurons in the substantia nigra (SN). Microglia-mediated neuroinflammation has been described as a common hallmark of PD and is believed to further trigger the progression of neurode...
Main Authors: | Stefan Jean-Pierre Haas, Xiaolai eZhou, Venissa eMachado, Andreas eWree, Kerstin eKrieglstein, Björn eSpittau |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-02-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2016.00007/full |
Similar Items
-
Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
by: Venissa Machado, et al.
Published: (2016-04-01) -
Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
by: Laura Hühner, et al.
Published: (2017-03-01) -
The Next Generation of Clinical Studies with Antidepressants in Bipolar Disorder
by: Rodrigo eMachado-Vieira, et al.
Published: (2014-03-01) -
Corrigendum: Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype
by: Eduardo R Zimmer, et al.
Published: (2016-04-01) -
Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease
by: Weizhao Chen, et al.
Published: (2022-05-01)